Pre-clinical AAV production and optimization: Not as easy as it looks! | GenScript

This webcast will discuss: Introduction to AAV in gene therapy. Some recent advances in viral vector production. Current challenges and solutions of pre-clinical AAV production. Adeno-associated virus (AAV) is the most popular vector of choice for gene therapy because of its low immunogenicity and ability to infect numerous cells and tissue types. However, with hundreds of gene therapy trials ongoing, manufacturing large quantities of viral vectors is becoming an increasing challenge. Services GenScript offers related to the topics discussed: Cell Engineering/Viral Vector Packaging: https://www.genscript.com/assay-cell-... ITR sequencing: https://www.genscript.com/itr-sequenc... Pre-clinical plasmid: https://www.genscript.com/preclinical...